The trademark application FOPal was filed by Clementia Pharmaceuticals Inc., a corporation established under the laws of Canada (the "Applicant"). The application was published for oppositions on November 29, 2022, and it was registered by office on March 8, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on January 11, 2024.
Goods And Services
The mark was filed in class 35 with Maintaining a registry of patient data and medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment and conducting business and market research surveys in the fields of pharmaceuticals and clinical trials..
The mark was filed in class 41 with Providing a website featuring educational information in the fields of pharmaceuticals and clinical trials.
The mark was filed in class 42 with Providing medical and scientific research information in the field of Fibrodysplasia ossificans progressiva (FOP) disease and treatment.
The mark was filed in class 44 with following description of goods:
Providing an online computer database featuring a registry of medical information and patient records
Medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment
Medical services, namely providing support in the observation, monitoring, adherence and medical treatments on patients
Health assessment services, namely, health-related surveys and questionnaires that produce treatment information
Conducting medical information surveys and questionnaires in the fields of disease and treatment, namely, conducting health surveys of patients with Fibrodysplasia ossificans progressiva (FOP) disease for medical purposes.